Synthesis and Cytotoxicity Evaluation of Small

Total Page:16

File Type:pdf, Size:1020Kb

Synthesis and Cytotoxicity Evaluation of Small Synthesis and Cytotoxicity evaluation of small 1,4 - triazolic derivatives against B16 melanoma cell lines and a methodolgy study on the synthesis of propargyl ethers from their corresponding propargyl esters without catalyst and under microwave irradiations Shiva Kalhor Monfared To cite this version: Shiva Kalhor Monfared. Synthesis and Cytotoxicity evaluation of small 1,4 - triazolic derivatives against B16 melanoma cell lines and a methodolgy study on the synthesis of propargyl ethers from their corresponding propargyl esters without catalyst and under microwave irradiations. Organic chemistry. Université Pierre et Marie Curie - Paris VI, 2014. English. NNT : 2014PA066235. tel- 01133657 HAL Id: tel-01133657 https://tel.archives-ouvertes.fr/tel-01133657 Submitted on 20 Mar 2015 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. THESE DE DOCTORAT DE L’UNIVERSITE PIERRE ET MARIE CURIE Spécialité Chimie Organique Ecole doctorale de Chimie Moléculaire Paris Centre Présentée par Mme Shiva Kalhor-Monfared Pour obtenir le grade de DOCTEUR de l’UNIVERSITÉ PIERRE ET MARIE CURIE Sujet de la thèse : Synthesis and Cytotoxicity evaluation of small 1,4-triazolic derivatives against B16 melanoma cell lines and a methodolgy study on the synthesis of propargyl ethers from their corresponding propargyl esters without catalyst and under microwave irradiations soutenue le 18 septembre 2014 devant le jury composé de : Mr F. Chemla, Examinateur Mr G. Prestat, Rapporteur Mr B. Vauzeilles, Rapporteur Mme Valérie Bénéteau, Examinatrice Mme Sandrine Sagan, Examinatrice Mr C. Girard, co-Directeur de thèse Mr J. Herscovici, Directeur de thèse Préparée à l’École Nationale Supérieure de Chimie de Paris 2 Synthesis and Cytotoxicity evaluation of small 1,4-triazolic derivatives against B16 melanoma cell lines and a methodology study on the synthesis of propargyl ethers from their corresponding propargyl esters without catalyst and under microwave irradiations By Shiva KALHOR MONFARED Dissertation Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Molecular Chemistry in the graduate college of 406 University of Pierre et Marie Curie prepared at Ecole Nationale Supérieure de Chimie de Paris Defense scheduled for 18 September 2014. Doctoral committee: Professor Fabrice Chemla, Examinor Professor Guillaume Prestat, Referee Doctor Boris Vauzeilles, Referee Doctor Sandrine Sagan, Examinor Doctor Valérie Bénéteau, Examinor Doctor Christian Girard, Ph.D. co-director Doctor Jean Herscovici, Ph.D. director 3 4 Acknowledgement I would like to take this time to thank Doctoral College 406 for all of the funding they were able to provide to me in order to make this thesis possible. I would also to express my special appreciation and thank to my advisor Dr. Christian Girard, you have been a tremendous mentor for me. I would like to thank you for encouraging my research and for following to grow as a research scientist. Your advice on both research as well as on my career have been priceless. I cannot forget Dr. Jean Herscovici, our previous lab director also my PhD directtor. However after only some months of my thesis you got retired, but even this short period let me to profit from your years of experience in organic synthesis, and I appreciate you for your availability in the lab even it was your last workdays. I would like also to special thank to Dr. Claire Beauvineau who was like my second advisor. I appreciate her voluntaries to help me through my project and give me good advices. You were not only a good advisor for my PhD work, but also you were like a consultant who helped me through the moments that I was not happy, you were always available to hear me, I really thank to you from the bottom of my heart. I would like also to thank my committee members, Pr. Fabrice Chemla, Pr. Giullaume Prestat, Dr. Boris Vauzeilles, Dr. Sandrine Sagan and Dr. Valérie Bénéteau. I extremely appreciate you to accept to be a member of my thesis committee. 5 I would like also to thank our colleagues in faculty of pharmacy, Dr. Johanne Seguin, Lionel Quentin and Dr. Guy Chabot who helped me to perform biological test on my molecules. Thanks a lot for your availability to answer my questions around biology and your guides. I, as a chemist was not ever able to do this work without your helps. Except these guys who helped me in my project, there were also other people in our research group who, with their presence made good moments for me in the lab. I would like to thank Dr. Fethi Bédioui, the responsible of our lab, Pr. Anne Varenne, Dr. Sophie Griveau, Dr. Mathiew Lazerge, Dr. Fanny Dorlye and Dr. Bich-Thuy Doan. Special thank to you Bich-Thuy for your guides in NMR. I won’t ever forget other people of the lab including PhD students and Postdocs or others, Riadh, Camille, Amandine, Abed, Gonzalo, Duc, Baptiste, Grégory, Abdelilah and Patrick (thank you Patrick. You were always smiley and trying to make me smile too. I was so happy because of your presence), and other temporary PhD students or trainings who worked for a short time with us. Thank to you to try to make the lab environment as funny as possible by organizing lab parties specially Mexican and Vietnamese ones that will stay forever in my mind. At the end, a special thank to my family. Words cannot express how grateful I am to my mother, and father for all of the sacrifices that you’ve made on my behalf. However you were not physically beside me, but your prayer for me was what sustained me thus far. I would also to thank my brothers Shahab and Shayan, and all of my friends who supported me during my PhD, and incented me to strive towards my goal. Thank you to all. 6 Table of contents General introduction………………………………………………………………………………17 Chapter 1: Diversity Oriented Synthesis and Click Chemistry………………………….......... 31 I. Introduction…………………………………………………………………………………...33 I.1.1. Source of small molecules for use in biological screens……………………………… 33 I.1.2. What is Diversity Oriented Synthesis……………………………………………..........34 I.1.2.1. Comparing DOS, TOS, and combinatorial chemistry……………………………...35 I.1.2.2. Molecular diversity…………………………………………………………………35 I.1.2.3. Skeletal diversity…………………………………………………………………...37 I.1.3. Screening small molecules for biological activity……………………………………...37 I.1.4. Discovering bioactive small molecules using DOS………………………………........39 I.1.4.1. Protein-protein interactions (PPIs)……………………………………………........39 1.1.5. Diversity Oriented Synthesis and chemical space……………………………………..40 I.2. Click Chemistry………………………………………………………………………….........41 I.2.1. Mechanism of Cu-catalyzed azide-alkyne cycloaddition…………………………........43 I.2.2. Physicochemical properties of organic azides…………………………………….........45 I.2.2.1. Reactions of organic azides……………………………………………………........47 I.2.2.2. Applications of azides…………………………………………………………........48 I.2.3. Applications of click chemical reactions………………………………………….........52 I.2.3.1. Therapeutics polymer………………………………………………………….........53 I.2.3.2. Drug delivery systems………………………………………………………............54 I.2.3.3. Bioconjugation………………………………………………………………….......56 I.2.3.3.1. Radiolabelling……………………………………………………………...........57 I.2.3.3.2. Polysaccharides………………………………………………………………….58 I.2.3.3.3. Tagging of live organisms and proteins……………………………………........59 I.2.3.3.4. Activity based protein profiling (ABPP)……………………………………......59 I.2.3.3.5. Labeling of DNA…………………………………………………………..........60 I.2.4. Synthesis of lead discovery libraries……………………………………………….......60 I.2.5. Limitations of Click Chemistry…………………………………………………….......61 I.2.6. Biologically active 1,2,3-triazoles………………………………………………….......62 I.2.7. Biologically active 1,2,3-triazoles synthesized without copper catalyst……………….62 I.2.8. Click reactions and the pharmacological applications of 1,2,3-triazoles………………63 I.2.8.1. Anticancer………………………………………………………………………......64 I.2.8.2. In vivo tumor cell targeting with ‘Click’ nanoparticles…………………………......66 Chapter II: Synthesis of triazolic derivatives departing from aldehydes and by use of a solid supported catalyst (A-21.CuI) and study their biological activity……………………………...69 II. Solid supported catalyst……………………………………………………………………...71 II.1. Synthesis of triazolic derivatives on a solid supported catalyst………………………....72 II.2. Amberlyst copper (I)-A-21 (A-21.CuI)……………………………………………….....76 II.2.1. Stability of Amberlyst A-21.CuI……………………………………………………..79 II.2.2. Limits of the Amberlyst A-21.CuI…………………………………………………...79 II.3. Synthesis of 1,2,3-triazoles derivatives from alkynes or propargylic alcohols……….....85 II.3.1. Terminal alkynes……………………………………………………………………..85 II.3.1.1. Seyferth-Gilbert homologation…………………………………………………...86 II.3.1.2. Mechanism of the Seyferth-Gilbert homologation……………………………….86 II.3.1.3. Bestmann-Ohira Reagent (BOR) reaction………………………………………..90 II.3.1.4. Mechanism of the alkynylation of an aldehyde with BOR………………………90 7 II.3.1.5. Some applications of Bestmann-Ohira reagent…………………………………..91 II.3.1.6. Synthesis of alkynes……………………………………………………………...96 II.3.1.6.1.
Recommended publications
  • Interstellar Ices and Radiation-Induced Oxidations of Alcohols
    The Astrophysical Journal, 857:89 (8pp), 2018 April 20 https://doi.org/10.3847/1538-4357/aab708 © 2018. The American Astronomical Society. All rights reserved. Interstellar Ices and Radiation-induced Oxidations of Alcohols R. L. Hudson and M. H. Moore Astrochemistry Laboratory, NASA Goddard Space Flight Center, Greenbelt, Maryland, 20771, USA; [email protected] Received 2017 May 2; revised 2018 March 8; accepted 2018 March 9; published 2018 April 18 Abstract Infrared spectra of ices containing alcohols that are known or potential interstellar molecules are examined before and after irradiation with 1 MeV protons at ∼20 K. The low-temperature oxidation (hydrogen loss) of six alcohols is followed, and conclusions are drawn based on the results. The formation of reaction products is discussed in terms of the literature on the radiation chemistry of alcohols and a systematic variation in their structures. The results from these new laboratory measurements are then applied to a recent study of propargyl alcohol. Connections are drawn between known interstellar molecules, and several new reaction products in interstellar ices are predicted. Key words: astrochemistry – infrared: ISM – ISM: molecules – molecular data – molecular processes 1. Introduction 668 cm−1 was produced in solid propargyl alcohol’sIR spectrum after the compound was irradiated with 2 keV Interstellar ices are now recognized as an important comp- electrons (Sivaraman et al. 2015, hereafter SMSB from the onent of the interstellar medium (ISM). The results of multiple coauthors final initials). That IR peak was assigned to benzene infrared (IR) surveys have led to over a dozen assignments of (C H ), which was said “to be the major product from spectral features to molecular ices, with the more abundant 6 6 propargyl alcohol irradiation.” However, a full mid-IR interstellar ices being H O, CO, and CO (Boogert et al.
    [Show full text]
  • Herbal Contraindications & Drug Interactions
    Herbal Contraindications & Drug Interactions plus Herbal Adjuncts with Medicines FOURTH EDITION, 2010 © by Francis Brinker, N.D. References 1. Sherman JA (comp.). The Complete Botanical Prescriber, 2nd ed. National College of Naturopathic Medicine, Portland, Ore., 1979 2. Brinker F. The Toxicology of Botanical Medicines, 3rd ed. Eclectic Medical Pub., Sandy, Ore., 2000 3. Brinker F. “Botanical Medicine Research Summaries,” from Eclectic Dispensatory of Botanical Therapeutics, vol. II. Eclectic Medical Pub., Sandy, Ore., 1995 4. Wichtl M (ed.). Herbal Drugs and Phytopharmaceuticals. CRC Press, Boca Raton, 1994 5. Felter HW, Lloyd JU. King’s American Dispensatory [1898]. Eclectic Medical Pub., Sandy, Ore., 1993 6. De Smet PAGM et al. (eds.). Adverse Effects of Herb Drugs 2. Springer-Verlag, Berlin, 1993 7. Lust J. The Herb Book. Bantam Books, New York, 1974 8. Boyd JR (ed.-in-chief). Facts and Comparisons. J.B. Lippincott Co., St. Louis, Miss., 1985 9. Ruddiman EA. Incompatibilities in Prescriptions. John Wiley & Sons, Inc., New York, 1925 10. Lewis WH, Elvin-Lewis MPF. Medical Botany. John Wiley & Sons, New York, 1977 11. Gibelli C. The hemostatic action of Equisetum. Arch. intern. pharmacodynamie, 41:419-429, 1931 (Chem. Abs. 26:6019) 12. Gutierrez RMP, Laguna GY, Walkowski, A. diuretic activity of Mexican Equisetum. J. Ethnopharm., 14:269- 272, 1985 13. Lepor H. Nonoperative management of benign prostatic hyperplasia. J. Urol., 141:1283-1289, 1989 14. Albert-Puleo M. Fennel and anise as estrogenic agents. J. Ethnopharm., 2:337-344, 1980 15. Albert-Puleo M. Mythobotany, pharmacology, and chemistry of thujone-containing plants and derivatives. Econ. Bot., 32:65-74, 1978 16.
    [Show full text]
  • Front Matter
    zpt0040800SPC1.qxd 3/11/08 10:55 AM Page 1 Volume 325 ■ Number 1 ■ April 2008 ■ ISSN 0022-3565 The Journal of PHARMACOLOGY And Experimental Therapeutics A Adaptations (Network Architecture) Can Create Unpredicted Therapeutic Actions Drug Predicted Effect Unexpected Effect B Complexity Creates Unpredicted Targets Predicted Effect Drug Target Unpredicted Target A Publication of the American Society for Pharmacology and Experimental Therapeutics Edited for the Society by Rick G. Schnellmann The Journal of PHARMACOLOGY And Experimental Therapeutics A Publication of the American Society for Pharmacology and Experimental Therapeutics April 2008 Vol. 325, No. 1 Contents PERSPECTIVES IN PHARMACOLOGY Exploiting Complexity and the Robustness of Network Marc K. Hellerstein 1 Architecture for Drug Discovery BEHAVIORAL PHARMACOLOGY Early Postnatal Stress Alters Place Conditioning to Both ␮- and Clifford C. Michaels and Stephen G. Holtzman 313 ␬-Opioid Agonists CARDIOVASCULAR □ ␤ S Design of Mutant 2 Subunits as Decoy Molecules to Reduce the Sabine Te´le´maque, Swapnil Sonkusare, 37 ,Expression of Functional Ca2؉ Channels in Cardiac Cells Terrie Grain, Sung W. Rhee, Joseph R. Stimers Nancy J. Rusch, and James D. Marsh Sphingosine 1-Phosphate Inhibits Nitric Oxide Production Takuji Machida, Yukihiro Hamaya, 200 Induced by Interleukin-1␤ in Rat Vascular Smooth Muscle Cells Sachiko Izumi, Yumika Hamaya, Kenji Iizuka, Yasuyuki Igarashi, Masaru Minami, Roberto Levi, and Masahiko Hirafuji Andrographolide Up-Regulates Cellular-Reduced Glutathione Anthony Y. H. Woo, Mary M. Y. Waye, 226 Level and Protects Cardiomyocytes against Stephen K. W. Tsui, Sandy T. W. Yeung, and Hypoxia/Reoxygenation Injury Christopher H. K. Cheng Orally Available Levosimendan Dose-Related Positive Inotropic Satoshi Masutani, Heng-Jie Cheng, 236 and Lusitropic Effect in Conscious Chronically Instrumented Minja Hyttila¨-Hopponen, Jouko Levijoki, Normal and Heart Failure Dogs Aira Heikkila¨, Arja Vuorela, William C.
    [Show full text]
  • Treatment Protocol Copyright © 2018 Kostoff Et Al
    Prevention and reversal of Alzheimer's disease: treatment protocol Copyright © 2018 Kostoff et al PREVENTION AND REVERSAL OF ALZHEIMER'S DISEASE: TREATMENT PROTOCOL by Ronald N. Kostoffa, Alan L. Porterb, Henry. A. Buchtelc (a) Research Affiliate, School of Public Policy, Georgia Institute of Technology, USA (b) Professor Emeritus, School of Public Policy, Georgia Institute of Technology, USA (c) Associate Professor, Department of Psychiatry, University of Michigan, USA KEYWORDS Alzheimer's Disease; Dementia; Text Mining; Literature-Based Discovery; Information Technology; Treatments Prevention and reversal of Alzheimer's disease: treatment protocol Copyright © 2018 Kostoff et al CITATION TO MONOGRAPH Kostoff RN, Porter AL, Buchtel HA. Prevention and reversal of Alzheimer's disease: treatment protocol. Georgia Institute of Technology. 2018. PDF. https://smartech.gatech.edu/handle/1853/59311 COPYRIGHT AND CREATIVE COMMONS LICENSE COPYRIGHT Copyright © 2018 by Ronald N. Kostoff, Alan L. Porter, Henry A. Buchtel Printed in the United States of America; First Printing, 2018 CREATIVE COMMONS LICENSE This work can be copied and redistributed in any medium or format provided that credit is given to the original author. For more details on the CC BY license, see: http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License<http://creativecommons.org/licenses/by/4.0/>. DISCLAIMERS The views in this monograph are solely those of the authors, and do not represent the views of the Georgia Institute of Technology or the University of Michigan. This monograph is not intended as a substitute for the medical advice of physicians. The reader should regularly consult a physician in matters relating to his/her health and particularly with respect to any symptoms that may require diagnosis or medical attention.
    [Show full text]
  • Tanibirumab (CUI C3490677) Add to Cart
    5/17/2018 NCI Metathesaurus Contains Exact Match Begins With Name Code Property Relationship Source ALL Advanced Search NCIm Version: 201706 Version 2.8 (using LexEVS 6.5) Home | NCIt Hierarchy | Sources | Help Suggest changes to this concept Tanibirumab (CUI C3490677) Add to Cart Table of Contents Terms & Properties Synonym Details Relationships By Source Terms & Properties Concept Unique Identifier (CUI): C3490677 NCI Thesaurus Code: C102877 (see NCI Thesaurus info) Semantic Type: Immunologic Factor Semantic Type: Amino Acid, Peptide, or Protein Semantic Type: Pharmacologic Substance NCIt Definition: A fully human monoclonal antibody targeting the vascular endothelial growth factor receptor 2 (VEGFR2), with potential antiangiogenic activity. Upon administration, tanibirumab specifically binds to VEGFR2, thereby preventing the binding of its ligand VEGF. This may result in the inhibition of tumor angiogenesis and a decrease in tumor nutrient supply. VEGFR2 is a pro-angiogenic growth factor receptor tyrosine kinase expressed by endothelial cells, while VEGF is overexpressed in many tumors and is correlated to tumor progression. PDQ Definition: A fully human monoclonal antibody targeting the vascular endothelial growth factor receptor 2 (VEGFR2), with potential antiangiogenic activity. Upon administration, tanibirumab specifically binds to VEGFR2, thereby preventing the binding of its ligand VEGF. This may result in the inhibition of tumor angiogenesis and a decrease in tumor nutrient supply. VEGFR2 is a pro-angiogenic growth factor receptor
    [Show full text]
  • Adducts of Propargyl Alcohol and Their Use As Corrosion Inhibitors in Acidizing Systems
    Europaisches Patentamt 19) s European Patent Office © Publication number: 0 239 770 Office europeen des brevets A1 © EUROPEAN PATENT APPLICATION © Application number: 87102356.0 © Int. CI.3: C 23 F 11/12 E 21 B 41/02, E 21 B 37/06 © Date of filing: 19.02.87 © Priority: 28.02.86 US 834526 © Applicant: BASF Corporation 9 Campus Drive Parsippany, NJ 07054(US) © Date of publication of application: 07.10.87 Bulletin 87/41 © Inventor: Perry, Christine 22335 Nixon © Designated Contracting States: Riverview Michigan 481 92(US) DE FR GB NL © Inventor: Crema,Stefano Carlo 1874 20th Street Wyandotte Michigan 48192(US) © Inventor: Davis, Pauls 30027 White Gibraltar Michigan 48173(US) @ Representative: Holler, Klaus, Dr. et al, BASF Aktiengesellschaft Carl-Bosch-Strasse 38 D-6700 Ludwigshafen(DE) © Adducts of propargyl alcohol and their use as corrosion inhibitors in acidizing systems. © The invention relates to an acidizing system comprising: (a) an acidizing solution; and (b) an effective corrosion inhibiting amount of a prop- argyl alcohol adduct having the following structural formula I: _ _ HC a C-CH2-0- -(CH2)5C-^ -H (I) wherein n = 1 or 3 and R = H if n = 3 and R = CH3 if n = 1 ; and x = 1 to 5. Corrosion of ferrous metals is inhibited by treating the surface thereof with the acidizing system. o IN M CM 0. Ul Croydon Printing Company Ltd. BASF Corporation ADDUCTS OF PROPARGYL ALCOHOL AND THEIR USE AS CORROSION INHIBITORS IN ACIDIZING SYSTEMS This invention relates to acidizing systems for oil and gas recovery containing propylene oxide and/or butylene oxide adducts of propargyl alcohol as corrosion inhibitors.
    [Show full text]
  • Chemical Name Federal P Code CAS Registry Number Acutely
    Acutely / Extremely Hazardous Waste List Federal P CAS Registry Acutely / Extremely Chemical Name Code Number Hazardous 4,7-Methano-1H-indene, 1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro- P059 76-44-8 Acutely Hazardous 6,9-Methano-2,4,3-benzodioxathiepin, 6,7,8,9,10,10- hexachloro-1,5,5a,6,9,9a-hexahydro-, 3-oxide P050 115-29-7 Acutely Hazardous Methanimidamide, N,N-dimethyl-N'-[2-methyl-4-[[(methylamino)carbonyl]oxy]phenyl]- P197 17702-57-7 Acutely Hazardous 1-(o-Chlorophenyl)thiourea P026 5344-82-1 Acutely Hazardous 1-(o-Chlorophenyl)thiourea 5344-82-1 Extremely Hazardous 1,1,1-Trichloro-2, -bis(p-methoxyphenyl)ethane Extremely Hazardous 1,1a,2,2,3,3a,4,5,5,5a,5b,6-Dodecachlorooctahydro-1,3,4-metheno-1H-cyclobuta (cd) pentalene, Dechlorane Extremely Hazardous 1,1a,3,3a,4,5,5,5a,5b,6-Decachloro--octahydro-1,2,4-metheno-2H-cyclobuta (cd) pentalen-2- one, chlorecone Extremely Hazardous 1,1-Dimethylhydrazine 57-14-7 Extremely Hazardous 1,2,3,4,10,10-Hexachloro-6,7-epoxy-1,4,4,4a,5,6,7,8,8a-octahydro-1,4-endo-endo-5,8- dimethanonaph-thalene Extremely Hazardous 1,2,3-Propanetriol, trinitrate P081 55-63-0 Acutely Hazardous 1,2,3-Propanetriol, trinitrate 55-63-0 Extremely Hazardous 1,2,4,5,6,7,8,8-Octachloro-4,7-methano-3a,4,7,7a-tetra- hydro- indane Extremely Hazardous 1,2-Benzenediol, 4-[1-hydroxy-2-(methylamino)ethyl]- 51-43-4 Extremely Hazardous 1,2-Benzenediol, 4-[1-hydroxy-2-(methylamino)ethyl]-, P042 51-43-4 Acutely Hazardous 1,2-Dibromo-3-chloropropane 96-12-8 Extremely Hazardous 1,2-Propylenimine P067 75-55-8 Acutely Hazardous 1,2-Propylenimine 75-55-8 Extremely Hazardous 1,3,4,5,6,7,8,8-Octachloro-1,3,3a,4,7,7a-hexahydro-4,7-methanoisobenzofuran Extremely Hazardous 1,3-Dithiolane-2-carboxaldehyde, 2,4-dimethyl-, O- [(methylamino)-carbonyl]oxime 26419-73-8 Extremely Hazardous 1,3-Dithiolane-2-carboxaldehyde, 2,4-dimethyl-, O- [(methylamino)-carbonyl]oxime.
    [Show full text]
  • Synthesis of Propargyl Alcohol Author(S)
    Studies on ethinylation reactions, II : synthesis of propargyl Title alcohol Author(s) Suzuki, Keizo The Review of Physical Chemistry of Japan (1954), 23(2): 66- Citation 72 Issue Date 1954-02-15 URL http://hdl.handle.net/2433/46699 Right Type Departmental Bulletin Paper Textversion publisher Kyoto University The Review of Physical Chemistry of Japan Vol. 23 No. 2 (1953) STUDIES ON ETHINYLATION REACTIONS, II Synthesis of Propargyl Alcohol By Ka¢c~ Sczcxi Introduction Propargyl alcohol is usually produced as the intermediate when butynediol-1, 4 is synthesized from acetylene and fornaldehyde, but it is to be possible to obtain propargyl alcohol as the main product if the conversion to butynediol can be checked by control- ling suitably the reaction conditions. W. Reppeil has obtained the satisfactory results in the synthesis of propargyl alcohol in a continuous process, while the unsuccessful result has been reported so far as a continuous process is adoptedzl. Therefore, it is expected that the synthesis of propargyl alcohol as the main product is difficult in com- parison with the case of butynediol. From the previous studies on the kinetics of the reaction of acetylene with aqueous formaldehyde solutiona~^>and the synthesis of butynediol in a continuous process sl, the results of the investigations on the propargyl alcohol synthesis are summarized as follows. The rate, the apparent equilibrium concentration of propargyl alcohol and the ratio in moles of the quantity of the propargyl alcohol formed to that of formaldehyde consumed, PfF increase when acetylene pressure is raised. In the cases where pH is low and the methanol content contained in an aqueous formaldehyde solution is high, the concentration of propargyl alcohol formed and P/F come to exceed the cases where pH is high and the methanol content is low, though the reaction rate is slow at the earlier stage.
    [Show full text]
  • Acutely / Extremely Hazardous Waste List
    Acutely / Extremely Hazardous Waste List Federal P CAS Registry Acutely / Extremely Chemical Name Code Number Hazardous 4,7-Methano-1H-indene, 1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro- P059 76-44-8 Acutely Hazardous 6,9-Methano-2,4,3-benzodioxathiepin, 6,7,8,9,10,10- hexachloro-1,5,5a,6,9,9a-hexahydro-, 3-oxide P050 115-29-7 Acutely Hazardous Methanimidamide, N,N-dimethyl-N'-[2-methyl-4-[[(methylamino)carbonyl]oxy]phenyl]- P197 17702-57-7 Acutely Hazardous 1-(o-Chlorophenyl)thiourea P026 5344-82-1 Acutely Hazardous 1-(o-Chlorophenyl)thiourea 5344-82-1 Extemely Hazardous 1,1,1-Trichloro-2, -bis(p-methoxyphenyl)ethane Extemely Hazardous 1,1a,2,2,3,3a,4,5,5,5a,5b,6-Dodecachlorooctahydro-1,3,4-metheno-1H-cyclobuta (cd) pentalene, Dechlorane Extemely Hazardous 1,1a,3,3a,4,5,5,5a,5b,6-Decachloro--octahydro-1,2,4-metheno-2H-cyclobuta (cd) pentalen-2- one, chlorecone Extemely Hazardous 1,1-Dimethylhydrazine 57-14-7 Extemely Hazardous 1,2,3,4,10,10-Hexachloro-6,7-epoxy-1,4,4,4a,5,6,7,8,8a-octahydro-1,4-endo-endo-5,8- dimethanonaph-thalene Extemely Hazardous 1,2,3-Propanetriol, trinitrate P081 55-63-0 Acutely Hazardous 1,2,3-Propanetriol, trinitrate 55-63-0 Extemely Hazardous 1,2,4,5,6,7,8,8-Octachloro-4,7-methano-3a,4,7,7a-tetra- hydro- indane Extemely Hazardous 1,2-Benzenediol, 4-[1-hydroxy-2-(methylamino)ethyl]- 51-43-4 Extemely Hazardous 1,2-Benzenediol, 4-[1-hydroxy-2-(methylamino)ethyl]-, P042 51-43-4 Acutely Hazardous 1,2-Dibromo-3-chloropropane 96-12-8 Extemely Hazardous 1,2-Propylenimine P067 75-55-8 Acutely Hazardous 1,2-Propylenimine 75-55-8 Extemely Hazardous 1,3,4,5,6,7,8,8-Octachloro-1,3,3a,4,7,7a-hexahydro-4,7-methanoisobenzofuran Extemely Hazardous 1,3-Dithiolane-2-carboxaldehyde, 2,4-dimethyl-, O- [(methylamino)-carbonyl]oxime 26419-73-8 Extemely Hazardous 1,3-Dithiolane-2-carboxaldehyde, 2,4-dimethyl-, O- [(methylamino)-carbonyl]oxime.
    [Show full text]
  • Predicting OH Stretching Fundamental Wavenumbers of Alcohols for Conformational Cite This: Phys
    PCCP View Article Online PAPER View Journal | View Issue Predicting OH stretching fundamental wavenumbers of alcohols for conformational Cite this: Phys. Chem. Chem. Phys., 2021, 23, 5629 assignment: different correction patterns for density functional and wave-function-based methods† Robert Medel * and Martin A. Suhm A model is presented for the prediction of OH stretching fundamental wavenumbers of alcohol conformers in the gas phase by application of a small set of empirical anharmonicity corrections to calculations in the harmonic approximation. In contrast to the popular application of a uniform scaling factor, the local chemical structure of the alcohol is taken into account to greatly improve accuracy. Interestingly, different correction patterns emerge for results of hybrid density functional (B3LYP-D3 and PBE0-D3) and wave-function-based Creative Commons Attribution 3.0 Unported Licence. methods (SCS-LMP2, LCCSD(T*)-F12a and CCSD(T)-F12a 1D). This raises questions about electronic structure deficiencies in these methods and differences in anharmonicity between alcohols. After its initial construction on the basis of literature assignments the model is tested with Raman jet spectroscopy of propargyl alcohol, Received 24th January 2021, cyclohexanol, borneol, isopinocampheol and 2-methylbutan-2-ol. For propargyl alcohol a spectral splitting Accepted 24th February 2021 attributed to tunneling is resolved. PBE0-D3 is identified as a well performing and broadly affordable À1 DOI: 10.1039/d1cp00342a electronic structure method for this model. A mean absolute error of 1.3 cm and a maximum absolute error of 3 cmÀ1 result for 46 conformers of 24 alcohols in a 60 cmÀ1 range, when a single parameter is rsc.li/pccp adjusted separately for each alcohol substitution class(methanol,primary,secondary,tertiary).
    [Show full text]
  • WO 2011/089216 Al
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date t 28 July 2011 (28.07.2011) WO 2011/089216 Al (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 47/48 (2006.01) C07K 1/13 (2006.01) kind of national protection available): AE, AG, AL, AM, C07K 1/1 07 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, (21) Number: International Application DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/EP201 1/050821 HN, HR, HU, ID, J , IN, IS, JP, KE, KG, KM, KN, KP, (22) International Filing Date: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, 2 1 January 201 1 (21 .01 .201 1) ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, (25) Filing Language: English SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, (26) Publication Language: English TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 1015 1465. 1 22 January 2010 (22.01 .2010) EP kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, (71) Applicant (for all designated States except US): AS- ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, CENDIS PHARMA AS [DK/DK]; Tuborg Boulevard TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, 12, DK-2900 Hellerup (DK).
    [Show full text]
  • The Role of Calcium and Mitochondria in the Etiology and Treatment of Three Different Disease Paradigms
    Health Science Campus FINAL APPROVAL OF DISSERTATION Doctor of Philosophy in Biomedical Sciences The Role of Calcium and Mitochondria in the Etiology and Treatment of Three Different Disease Paradigms Submitted by: Christine Brink In partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biomedical Sciences Examination Committee Major Advisor: David Giovannucci, Ph.D. Academic Linda Dokas, Ph.D. Advisory Committee: Joseph Margiotta, Ph.D. Andrew Beavis, Ph.D. Ana Marie Oyarce, Ph.D. L. John Greenfield, M.D., Ph.D. Senior Associate Dean College of Graduate Studies Michael S. Bisesi, Ph.D. Date of Defense: December 7, 2007 The Role of Calcium and Mitochondria in the Etiology and Treatment of Three Different Disease Paradigms Christine A. Brink University of Toledo, Health Science Campus 2007 Acknowledgements First, I would like to thank my advisor, Dr. David Giovannucci, for his encouragement and support throughout my graduate training. His advice and understanding have been essential to my success over the past 5 years. I will always be grateful for the education he has provided to me, and the compassion he has shown toward me. Next, I would like to thank Jenny Giovannucci for her illustrations and encouragement. I would also like to thank Rebecca Pierson for providing the primary cortical neuronal cultures, and countless words of advice. Additionally, I would like to thank Christian Peters for his counsel and assistance throughout our training. In addition, I would like to thank my committee members, Dr. Greenfield, Dr. Dokas, Dr. Margiotta, Dr. Beavis, and Dr. Oyarce, for their contributions and guidance.
    [Show full text]